Variations in plasma levels of substance P and effects of a specific substance P antagonist of the NK(1) receptor on preovulatory LH and FSH surges and progesterone secretion in the cycling cynomolgus monkey.
These studies investigated the role of substance P (SP) in the regulation of the hypothalamic-pituitary-ovarian axis in cynomolgus monkeys with normal menstrual cycles. Plasma concentrations of SP were determined in blood samples taken every morning in normally menstruating cynomolgus monkeys throughout the menstrual cycle. There was a significant decreasing linear trend of SP during the follicular phase (cycle day -13 to day 0) and a significant inverse relationship between SP plasma values and plasma 17beta-estradiol (E(2)) values from day -13 to day 0 of the adjusted cycle. Correspondingly, SP area under the curve was significantly greater during the follicular phase than the luteal phase. In a second experiment, plasma concentrations of E(2), luteinizing hormone (LH), follicle-stimulating hormone (FSH) and progesterone and length of cycles were measured after five daily intragastric administrations (10 mg/kg) of an NK(1) receptor (SP receptor) antagonist (RPR 100893; 10 mg/kg) initiated after serum E(2) concentrations had exceeded 125 pg/ml. There was a statistically significant reduction in the amplitude (41% of control) and the area under the curve (37% of control) of the preovulatory LH surge. In addition, there was a reduction of the duration of the LH surge (3 +/- 0.1 days in controls vs. 2.1 +/- 0.2 days in treated animals). The present results show for the first time that there are significant variations in plasma levels of SP, with a strong negative correlation with serum levels of E(2) during the follicular phase of the cynomolgus monkey, and that endogenous SP has a potentiating role in the interactive hypothalamo-anterior-pituitary mechanisms which lead to the preovulatory LH and FSH surges during the menstrual cycle in the monkey.
Kerdelhué
B
B
Laboratoire de Neurobiologie Cellulaire et Moléculaire, CNRS E.P. 1591, Faculté de Pharmacie, Paris, France. Kerdelhu@pharmacie.univ-paris5.fr
Williams
R F
RF
Lenoir
V
V
Fardin
V
V
Kolm
P
P
Hodgen
G D
GD
Jones
G S
GS
Scholler
R
R
Jones
H W
HW
D000818:Animals; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D005498:Follicular Phase / Q000187:drug effects / Q000502:physiology*; D007211:Indoles / Q000494:pharmacology; D054833:Isoindoles; D007986:Luteinizing Hormone / Q000097:blood*; D008252:Macaca fascicularis; D064729:Neurokinin-1 Receptor Antagonists; D010060:Ovulation / Q000502:physiology; D011374:Progesterone / Q000097:blood / Q000378:metabolism; D018040:Receptors, Neurokinin-1 / Q000502:physiology*; D013373:Substance P / Q000037:antagonists & inhibitors / Q000097:blood*
D007211:Indoles; D054833:Isoindoles; D064729:Neurokinin-1 Receptor Antagonists; D018040:Receptors, Neurokinin-1; C089835:RPR 100893; D013373:Substance P; D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone